Page last updated: 2024-12-07

methyl methanethiosulfinate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methyl methanethiosulfinate: structure in first source; a metabolite of S-methyl cysteine sulfoxide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID95200
CHEMBL ID403038
CHEBI ID184354
SCHEMBL ID862565
MeSH IDM0219566

Synonyms (33)

Synonym
nsc-23129
nsc23129
13882-12-7
methyl methanethiosulfinate
methanesulfinic acid, thio-, s-methyl ester (6ci,7ci,8ci)
methyl methane thiosulphinate
dimethyl thiosulfinate
s-methyl thiomethanesulfinate
methanesulfinothioic acid, s-methyl ester
brn 1738960
s-methyl methanethiosulfinate
dimethyldisulfide, s-oxide
CHEMBL403038 ,
s-methylmethane thiosulfinate
CHEBI:184354
(methanesulfinylsulfanyl)methane
methylsulinylsulanylmethane
methylsulfinylsulfanylmethane
AKOS006278759
methylsulfinylsulfanyl-methane
nsc 23129
4-04-00-00004 (beilstein handbook reference)
methanesulfinic acid, thio-, s-methyl ester
SCHEMBL862565
RRGUMJYEQDVBFP-UHFFFAOYSA-N
s-methyl methanesulfinothioate
c2h6os2
s-methyl methane thiosulfinate
bdbm50540965
DTXSID601310808
EN300-213506
mfcd01754729
SY359048

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
sulfur oxoacid derivative
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
methiin metabolism216

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Beta-glucuronidaseEscherichia coli K-12IC50 (µMol)3.60001.60002.60003.6000AID1656434
Beta-glucuronidaseHomo sapiens (human)IC50 (µMol)3.60000.02003.08337.4000AID1656436
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (6)

Processvia Protein(s)Taxonomy
glucuronoside catabolic processBeta-glucuronidaseEscherichia coli K-12
carbohydrate metabolic processBeta-glucuronidaseEscherichia coli K-12
glucuronoside catabolic processBeta-glucuronidaseEscherichia coli K-12
carbohydrate metabolic processBeta-glucuronidaseHomo sapiens (human)
glycosaminoglycan catabolic processBeta-glucuronidaseHomo sapiens (human)
heparan sulfate proteoglycan catabolic processBeta-glucuronidaseHomo sapiens (human)
chondroitin sulfate catabolic processBeta-glucuronidaseHomo sapiens (human)
hyaluronan catabolic processBeta-glucuronidaseHomo sapiens (human)
glucuronoside catabolic processBeta-glucuronidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
hydrolase activity, hydrolyzing O-glycosyl compoundsBeta-glucuronidaseEscherichia coli K-12
beta-glucuronidase activityBeta-glucuronidaseEscherichia coli K-12
hydrolase activity, acting on glycosyl bondsBeta-glucuronidaseEscherichia coli K-12
identical protein bindingBeta-glucuronidaseEscherichia coli K-12
carbohydrate bindingBeta-glucuronidaseEscherichia coli K-12
beta-glucuronidase activityBeta-glucuronidaseHomo sapiens (human)
signaling receptor bindingBeta-glucuronidaseHomo sapiens (human)
protein domain specific bindingBeta-glucuronidaseHomo sapiens (human)
carbohydrate bindingBeta-glucuronidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
cytosolBeta-glucuronidaseEscherichia coli K-12
protein-containing complexBeta-glucuronidaseEscherichia coli K-12
extracellular regionBeta-glucuronidaseHomo sapiens (human)
extracellular spaceBeta-glucuronidaseHomo sapiens (human)
membraneBeta-glucuronidaseHomo sapiens (human)
azurophil granule lumenBeta-glucuronidaseHomo sapiens (human)
lysosomal lumenBeta-glucuronidaseHomo sapiens (human)
intracellular membrane-bounded organelleBeta-glucuronidaseHomo sapiens (human)
extracellular exosomeBeta-glucuronidaseHomo sapiens (human)
ficolin-1-rich granule lumenBeta-glucuronidaseHomo sapiens (human)
extracellular spaceBeta-glucuronidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (28)

Assay IDTitleYearJournalArticle
AID317135Increase in Bax protein expression in human PC3 cells by Western blot2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317139Induction of apoptosis in human PC3 cells assessed as caspase 3 activity at 5 ug/mL2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317137Induction of Bid protein cleavage in human PC3 cells by Western blot2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317134Induction of cell death in human PC3 cells in presence of caspase inhibitor Z-VAD-fmk2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317125Induction of apoptosis in human PC3 cells assessed as DNA fragmentation at 5 ug/mL after 24 hrs by ELISA relative to control2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317141Induction of apoptosis in human PC3 cells assessed as caspase 3 activity at 20 ug/mL2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317126Induction of apoptosis in human PC3 cells assessed as DNA fragmentation at 10 ug/mL after 24 hrs by ELISA relative to control2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317119Cytotoxicity against human PC3 cells after 24 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317118Cytotoxicity against human LNCap cells after 24 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317129Induction of PARP cleavage in human PC3 cells after 24 hrs by Western blot2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317131Induction of apoptosis in human PC3 cells assessed as caspase 9 activity at 10 ug/mL relative to control2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317127Induction of apoptosis in human PC3 cells assessed as DNA fragmentation at 20 ug/mL after 24 hrs by ELISA relative to control2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317121Growth inhibition of human PC3 cells by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317140Induction of apoptosis in human PC3 cells assessed as caspase 3 activity at 10 ug/mL2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317130Induction of apoptosis in human PC3 cells assessed as caspase 8 activity at 10 ug/mL relative to control2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317124Induction of apoptosis in human PC3 cells after 24 hrs by Hoechst staining2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID1656436Inhibition of beta-glucuronidase (unknown origin)2020European journal of medicinal chemistry, Feb-01, Volume: 187Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.
AID317142Increase in AIF protein levels in human PC3 cells after 24 hrs by Western blot2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317123Induction of cell death in human PC3 cells by trypan blue assay2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID1656434Inhibition of Escherichia coli beta-glucuronidase2020European journal of medicinal chemistry, Feb-01, Volume: 187Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.
AID317136Decrease in Bcl2 protein expression in human PC3 cells by Western blot2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317133Reversal of induction of apoptosis in human PC3 cells in presence of caspase inhibitor Z-VAD-fmk2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317128Cell cycle arrest in human PC3 cells assessed as accumulation at subG1 phase after 24 hrs by flow cytometry2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317138Induction of AIF protein translocation into nucleus in human PC3 cells after 24 hrs by immunostaining2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317120Cytotoxicity against human DU145 cells after 24 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317132Induction of apoptosis in human PC3 cells assessed as caspase 3 activity at 10 ug/mL relative to control2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317122Growth inhibition of human PC3 cells assessed as decrease in cell numbers by trypan blue assay2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
AID317117Cytotoxicity against human RC58T/h/SA#4 cells after 24 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (15.38)18.2507
2000's4 (30.77)29.6817
2010's5 (38.46)24.3611
2020's2 (15.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.10 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]